We gratefully acknowledge the University of California, Berkeley, NIHGMS (R01 GM073932-01), Merck Research Laboratories, Bristol-Myers Squibb, Amgen Inc., DuPont, GlaxoSmithKline, Eli Lilly & Co., Pfizer, AstraZeneca, and Roche for financial support.
Total Synthesis of (+)-Fawcettimine†
Article first published online: 29 AUG 2007
Copyright © 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Angewandte Chemie International Edition
Volume 46, Issue 40, pages 7671–7673, October 8, 2007
How to Cite
Linghu, X., Kennedy-Smith, Joshua J. and Toste, F. Dean. (2007), Total Synthesis of (+)-Fawcettimine. Angew. Chem. Int. Ed., 46: 7671–7673. doi: 10.1002/anie.200702695
- Issue published online: 28 SEP 2007
- Article first published online: 29 AUG 2007
- Manuscript Received: 19 JUN 2007
- University of California, Berkeley
- NIHGMS. Grant Number: R01 GM073932-01
- Merck Research Laboratories
- Bristol-Myers Squibb
- Amgen Inc.
- Eli Lilly & Co.
- total synthesis
An effective combination: With the first asymmetric total synthesis of fawcettimine (1) it has been shown that the use of organocatalytic annulation and gold(I)-catalyzed cyclization reactions provides an effective combination for the synthesis of complex molecules. The absolute configuration of 1 was established through an X-ray structure analysis of its hydrobromide.